You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Glucagon‐like peptide analogues for type 2 diabetes mellitus
|
---|---|
Published in |
Cochrane database of systematic reviews, October 2011
|
DOI | 10.1002/14651858.cd006423.pub2 |
Pubmed ID | |
Authors |
Deepson S. Shyangdan, Pamela Royle, Christine Clar, Pawana Sharma, Norman Waugh, Ailsa Snaith |
Abstract |
Glucagon-like peptide analogues are a new class of drugs used in the treatment of type 2 diabetes that mimic the endogenous hormone glucagon-like peptide 1 (GLP-1). GLP-1 is an incretin, a gastrointestinal hormone that is released into the circulation in response to ingested nutrients. GLP-1 regulates glucose levels by stimulating glucose-dependent insulin secretion and biosynthesis, and by suppressing glucagon secretion, delayed gastric emptying and promoting satiety. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 17% |
United States | 1 | 17% |
Unknown | 4 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Scientists | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 539 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 3 | <1% |
Brazil | 3 | <1% |
Germany | 2 | <1% |
Netherlands | 2 | <1% |
United States | 2 | <1% |
Ireland | 1 | <1% |
Singapore | 1 | <1% |
France | 1 | <1% |
Russia | 1 | <1% |
Other | 1 | <1% |
Unknown | 522 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 74 | 14% |
Researcher | 70 | 13% |
Student > Bachelor | 64 | 12% |
Student > Ph. D. Student | 50 | 9% |
Student > Postgraduate | 45 | 8% |
Other | 106 | 20% |
Unknown | 130 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 235 | 44% |
Nursing and Health Professions | 26 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 24 | 4% |
Biochemistry, Genetics and Molecular Biology | 22 | 4% |
Agricultural and Biological Sciences | 20 | 4% |
Other | 67 | 12% |
Unknown | 145 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2023.
All research outputs
#3,430,408
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,035
of 11,842 outputs
Outputs of similar age
#17,809
of 144,888 outputs
Outputs of similar age from Cochrane database of systematic reviews
#52
of 130 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,888 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 130 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.